BNP Paribas Fortis Private Equity
Brussels, Brussels-Capital Regioncompanies.bnpparibasfortis.be
Overview
BNP Paribas Fortis Private Equity is the private equity branch of BNP Paribas Fortis and has been active in the Belgian market since 1982. It functions as a growth equity firm, providing (quasi-) equity support to scale-ups and mature, profitable companies in Belgium. The firm invests directly by taking minority stakes or providing mezzanine financing, and also invests indirectly in other diversified private equity funds. It focuses on all sectors except real estate and does not operate under a closed-end fund structure, allowing for long-term investment horizons. Capital for direct investments is sourced from the bank's own balance sheet.
Portfolio Companies
20
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EPICS Therapeutics | Sep 2025 | Early Funding | Co-investor |
| MRM Health | Sep 2025 | Series B | Co-investor |
| Aerospacelab | Aug 2025 | Series B | Co-investor |
| Solora | Dec 2024 | Growth Equity | Lead |
| Anima Research Center | Nov 2024 | Private Equity | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.